MarketPeel
Insider Trading Intelligence
Pricing
…
DP

David E. I. Pyott

TARS
DIRECTOR · TARSUS PHARMACEUTICALS, INC. · CIK 0001051578
FILING MIX · LIFETIME67%/33%
BUYS
38
SELLS
19
TOTAL VALUE
$15.83M
COMPANIES
5
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
82,155
AVG SELL PX
$229.74
TRADE KIND
SHOWING 57 / 57
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by David E. I. Pyott, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+14.29%+1.90%-1.01%+2.91%+0.07%—
14d7+14.29%+2.58%-1.07%+3.66%-0.34%—
30d7+28.57%-1.74%-2.65%+0.91%+1.25%—
60d7+28.57%+3.95%-3.38%+7.33%+1.53%—
90d7+42.86%+7.93%+2.36%+5.57%+3.17%—
180d7+14.29%+10.04%+9.41%+0.63%+0.49%—
1y7+28.57%+25.41%+19.24%+6.17%-1.25%—
2y7(1 pending)+33.33%+28.52%+30.68%-2.15%-4.01%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TARS · 806 shares · as of Jun 25, 2026
01,4732,9474,4205,893SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 38 buys / 19 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
806——806Jun 25, 2026Jun 29, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,837——3,837Jun 25, 2026Jun 29, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,417——2,417Jun 25, 2026Jun 29, 2026 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,222$299.87$366.4K2,094Jun 1, 2026Jun 3, 2026 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
3,830——0Jun 1, 2026Jun 3, 2026 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,175$298.91$351.2K3,316Jun 1, 2026Jun 3, 2026 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
921$297.71$274.2K4,491Jun 1, 2026Jun 3, 2026 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
495$300.72$148.9K1,599Jun 1, 2026Jun 3, 2026 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
3,830——5,412Jun 1, 2026Jun 3, 2026 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
17$302.65$5.1K1,582Jun 1, 2026Jun 3, 2026 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
671——1,582May 20, 2026May 22, 2026 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,441——1,441May 20, 2026May 22, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
1,383——0Apr 24, 2026Apr 28, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
1,383——1,383Apr 24, 2026Apr 28, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,893——5,893Feb 18, 2026Feb 20, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,729——3,729Feb 18, 2026Feb 20, 2026 ↗View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,000——30,000Jun 5, 2025Jun 9, 2025 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
775——911May 8, 2025May 12, 2025 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,558——1,558May 8, 2025May 12, 2025 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
7,440$299.00$2.22M136Mar 24, 2025Mar 25, 2025 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
7,440$88.95$661.8K7,576Mar 24, 2025Mar 25, 2025 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
7,440——0Mar 24, 2025Mar 25, 2025 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
7,470——3,780Jun 24, 2024Jun 26, 2024 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
7,470$71.99$537.8K32,586Jun 24, 2024Jun 26, 2024 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
7,420$70.20$520.9K25,116Jun 24, 2024Jun 26, 2024 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
7,420——3,830Jun 24, 2024Jun 26, 2024 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
17,560$220.00$3.86M15,026Jun 24, 2024Jun 26, 2024 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
17,560——7,440Jun 24, 2024Jun 26, 2024 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
17,560$88.95$1.56M17,696Jun 24, 2024Jun 26, 2024 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
7,420$221.00$1.64M7,606Jun 24, 2024Jun 26, 2024 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
7,470$222.00$1.66M136Jun 24, 2024Jun 26, 2024 ↗View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,764——26,764Jun 13, 2024Jun 17, 2024 ↗View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
4,720——49,750May 21, 2024May 23, 2024 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,228——5,228May 16, 2024May 20, 2024 ↗View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,000——14,000Jun 7, 2023Jun 8, 2023 ↗View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
4,190——45,030May 23, 2023May 24, 2023 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,454——3,454May 18, 2023May 19, 2023 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
SALE
136——0Feb 23, 2023Feb 27, 2023 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASE
136——136Feb 23, 2023Feb 27, 2023 ↗View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jun 16, 2022Jun 21, 2022 ↗View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
4,980——40,840May 24, 2022May 26, 2022 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,153——5,153May 18, 2022May 20, 2022 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
136——136Feb 23, 2022Feb 25, 2022 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,032——4,032Jul 15, 2021Jul 19, 2021 ↗View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
13,286——13,286Jun 29, 2021Jun 30, 2021 ↗View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
13,286——13,286Jun 29, 2021Jul 1, 2021 ↗View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
5,120——35,860May 25, 2021May 27, 2021 ↗View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,573——26,573Jan 12, 2021Jan 13, 2021 ↗View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASE
11,900$78.22$930.8K29,840Aug 31, 2020Sep 1, 2020 ↗View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASE
900$78.84$71.0K30,740Aug 31, 2020Sep 1, 2020 ↗View →
ALNY
ALNYLAM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,581——4,581Jul 1, 2020Jul 6, 2020 ↗View →
BMRN
BIOMARIN PHARMACEUTICAL INC
PURCHASEGRANT
Stock grant
4,300——17,940May 27, 2020May 29, 2020 ↗View →
AVY
AVERY DENNISON CORP
PURCHASE
1,414$107.56$152.1K18,684Apr 23, 2020Apr 24, 2020 ↗View →
AVY
AVERY DENNISON CORP
SALE
1,414——0Apr 23, 2020Apr 24, 2020 ↗View →
AVY
AVERY DENNISON CORP
PURCHASE
5,027$38.18$191.9K22,297Feb 3, 2020Feb 5, 2020 ↗View →
AVY
AVERY DENNISON CORP
SALE
5,027——0Feb 3, 2020Feb 5, 2020 ↗View →
AVY
AVERY DENNISON CORP
SALE
5,027$132.72$667.2K17,270Feb 3, 2020Feb 5, 2020 ↗View →
Other insiders · TARS
Loading peer insiders…
About this filer
CIK 0001051578
ROLE
Director
PRIMARY
TARS
COMPANIES
5
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001051578DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback